Purpose: To automate dynamic contrast-enhanced MRI (DCE-MRI) data analysis by unsupervised pattern recognition (PR) to enable spatial mapping of intratumoral vascular heterogeneity. Methods: Three steps were automated. First, the arrival time of the contrast agent at the tumor was determined, including a calculation of the precontrast signal. Second, four criteriabased algorithms for the slice-specific selection of number of patterns (NP) were validated using 109 tumor slices from subcutaneous flank tumors of five different tumor models. The criteria were: half area under the curve, standard deviation thresholding, percent signal enhancement, and signal-to-noise ratio (SNR). The performance of these criteria was assessed by comparing the calculated NP with the visually determined NP. Third, spatial assignment of single patterns and/or pattern mixtures was obtained by way of constrained nonnegative matrix factorization. Results: The determination of the contrast agent arrival time at the tumor slice was successfully automated. For the determination of NP, the SNR-based approach outperformed other selection criteria by agreeing >97% with visual assessment. The spatial localization of single patterns and pattern mixtures, the latter inferring tumor vascular heterogeneity at subpixel spatial resolution, was established successfully by automated assignment from DCE-MRI signal-versus-time curves. Conclusion: The PR-based DCE-MRI analysis was successfully automated to spatially map intratumoral vascular heterogeneity.
INTRODUCTION
The tumor microenvironment is heterogeneous, exhibiting severe functional vascular abnormalities (1) (2) (3) . Dynamic contrast-enhanced MRI (DCE-MRI) is used to assess tumor blood flow and permeability clinically and preclinically, after the administration of the contrast agent (CA) gadopentetate dimeglumine (Gd-DTPA), with < 30 min (clinically typically 5-10 min) scan times and high spatial resolution (<200 mm preclinically and 1-2 mm clinically) (4) (5) (6) (7) (8) . Parameters from tracer-kinetic modeling of signal-versus-time DCE-MRI curves (4, 9, 10) have been used to differentiate tumor microenvironments (5, 6, 11, 12) and to longitudinally monitor vascular changes in response to treatments (6, (13) (14) (15) . Various pattern analysis approaches, including machine learning, have been used to extract features to improve tumor classification and, to a lesser extent, assess intratumoral heterogeneity to guide treatment or gauge prognosis (16) (17) (18) (19) (20) (21) (22) (23) .
Using preclinical in vivo imaging modalities coregistered with pathology, we have shown previously that well-vascularized (i.e., well-perfused) tumor areas are characterized by rapid Gd-DTPA uptake/washout, that hypoxic areas exhibit reduced vascular function associated with delayed Gd-DTPA uptake/washout, and that necrotic areas exhibit slow or no CA uptake and no discernible washout over the experimental observation (12, 24, 25) . We categorized these tumor microenvironments based on their representative DCE-MRI signal-versus-time curves by pattern recognition (PR), using the Gaussian mixture model or constrained nonnegative matrix factorization (cNMF) (24, 25) . The semiautomatic PR approach required manual input of the number of patterns (NP) in the DCE-MRI data. The variable (subjective) application of a fixed NP for all tumor slices may lead to overfitting (or underfitting) in tumors or tumor slices that are characterized by more (or fewer) patterns than predefined, thus disregarding intratumoral heterogeneity represented by disparate DCE-MRI curves and physiological environments across tumor slices (Fig. 1) .
The goal of this study was to optimize and automate DCE-MRI data analysis using our previously described unsupervised PR approach (24) to accurately and fully automate the identification of vascularity-driven intratumoral heterogeneity using cNMF. This model involves novel automatic approaches to determine the NP for each DCE-MRI slice, to spatially map intratumoral heterogeneities, and to incorporate the computerized determination of the precontrast signal. A stepwise scheme of the analysis process is shown in Figure 2 . All analysis steps were coded in MATLAB (MathWorks, Inc. Natick, Massachusetts, USA). In vivo DCE-MRI was performed using a custom-built solenoid 1 H MR coil on a horizontal-bore Bruker 7T magnet (Bruker Biospin, Germany). A bolus of 0.2 mmol/kg Gd-DTPA (Magnevist; Berlex Laboratories, Inc., Wayne, New Jersey, USA) was administered intravenously via a tail vein catheter. During the MR experiment, mice were anesthetized with <2% isoflurane in oxygen. The breathing rate was kept at 50-90 breaths/min by adjusting the isoflurane level. The rodent core temperature was maintained at 34 C-37 C. After tumor positioning, 1 H MR coil tuning and matching, the water line width was optimized to approximately 30-70 Hz full-width-half-maximum by field map-based shimming. To assess tumor vascularity, DCE-MRI data were acquired using a T 1 -weighted fast low-angle shot (30) (b) Corresponding cNMF maps (left) of the tumor slice depicted in (a) with associated cNMF curves (right) for NP set to 2 (top) and 3 (bottom), respectively. For NP ¼ 2, two distinct cNMF patterns were identified; for NP ¼ 3, however, the second and third pattern were very noisy and showed overlap due to data overfitting, resulting in an inability to reproducibly/accurately assign a pixel to pattern 2 or 3. (c) In a second example, PCA of two slices of a heterogeneous HEK flank tumor (HEK #1), the first five PCs, and their corresponding weight maps are displayed. The percent variability of each PC to explain the contrast agent (CA) uptake behavior in their respective slice is shown below each PC. Despite the percent contribution to the overall signal of the 3 rd PC in slice 1 and 2 being similar (0.19% and 0.15% respectively), the numbers of significant signal-related PCs identified visually for slice 1 and slice 2 are 2 and 3, respectively, as the signal in the third PC in slice 1 is within twice the size of the noise and similar to higher-order PCs. The overall signal explained by the number of significant signal-related PCs is 98.08% in slice 1 and 98.89% in slice 2. The varying NP between slices attests to the vascular heterogeneity of this tumor across the thickness of the tumor.
METHODS
All animal studies complied with protocols approved by the Institutional Animal Care and Use Committee of Memorial Sloan Kettering Cancer Center.
Data Loading and Determination of Mean Precontrast Signal S 0
For each image slice, text image masks, outlining the entire tumor area (i.e., the region of interest [ROI]), were created using ImageJ (National Institutes of Health, Bethesda, Maryland, USA) from ROIs drawn manually on processed (Fourier-transformed, magnitude calculated) MR images acquired with 1 NR and 500 ms TR (other parameters equal those for DCE-MRI) (Fig. 2, first  step) . Sequence parameters, DCE-MR images, and ROI masks in each slice were loaded using a graphic user interface (Fig. 2, first step) . To automatically identify the time point of the CA arriving at the tumor tissue (NR CA ), the derivative of the average signal-versus-time curve was calculated for each ROI. An example curve is depicted in Figure 2 (second step). The largest signal difference (red arrow, Fig. 2 , second step) corresponded to the NR CA . The lowest NR of the time points with the top 10 highest signal changes was selected to reduce the chance of erroneously identifying a later time point as NR CA . The precontrast signal S 0 was obtained by averaging the signal between NR 1 and NR CA with the first and last five NRs excluded to minimize errors due to signal distortions at the start of the DCE-MRI scan and due to potentially missing points that may already show enhancement but not the largest change (Fig. 2, second  step) . It was used to calculate baseline-corrected signal (signal-S 0 ) and normalized signal (signal/S 0 )-versus-time curves.
Principal Component Analysis: Approaches for Automatic Determination of NP
Principal component analysis (PCA) (31, 32) , which identifies the sources of largest variations (principal components [PCs] ) is applied to the baseline-corrected signal (Fig. 2, third step) . It was conducted through singular value decomposition of the data covariance matrix (24) . For each pixel, signal-versus-time curves [S(x, t), with spatial location x and dynamic time frame t 5 NR 1 ,. . .,NR 256 ] extracted from DCE-MRI data were resolved as the weighted sum of the PCs. Orthonormal PCs were ordered by decreasing amounts of variability.
Comparing the NP, determined by 1-3 readers (S.H., R.S., and E.A.) based on PC curve characteristics (signal PCðt; kÞ Á F k (i.e., the sum of the precontrast time points of all PC curves [t 5 5 to t 5 (NR CA -5NR)]) with k th PC weighted by its percent contribution F k to the overall signal, leads to the selection of only significant patterns (NP), and is given by
The maximum i for which SD Th (i) (i.e., the sum over all time points of all weighted PC curves [k ¼ [3] where max represents the maximum "signal" height, t Enh represents the time frame from CA arrival until the end of the DCE-MRI acquisition (NR CA to NR 256 ), mean represents the average signal height, and t BL represents the time frame covering the precontrast acquisition from which S 0 is calculated. A threshold of S Enh ¼ 6000 was set empirically to select the NP contributing significantly to the portrayal of the signal-versus-time curves, by optimizing agreement with visually determined NP as more tumor slices were added to the analysis. The fourth criterion, signal-to-noise ratio (SNR), is defined as SNRðkÞ ¼ max PCðt Enh ; kÞ 4 Â SD PCðt BL ; kÞ [4] with the noise (above which the signal has to rise) defined by SD that is four times the standard deviation of the mean of PC(t BL ,k). Guided by the Rose Criterion (33, 34) , an SNR threshold of 5 was set to assure 100% certainty in distinguishing the PC signal from the noise (35) . In cases of low or no contrast enhancement (e.g., necrotic tumors) with an SNR of the first PC between 2 and 5, the number of significant PCs was set to 1.
To assess the performance of these criteria, calculated NP were compared with NP determined visually.
cNMF and Pattern Assignments
The orthonormal PCs are not able to represent signalversus-time curves directly, because the latter are not commonly orthonormal (24) . However, PCs are useful to characterize the number of uncorrelated, significant signal-related patterns (NP) underlying the signal-versustime curves of DCE-MRI data. Therefore, as described previously (24), cNMF (36) (37) (38) , an unsupervised PR approach, is used to describe each pixel's normalized signal-versus-time curve by the NP patterns (cNMF curves, which are not orthonormal unlike the PCs) and their corresponding weights without significant loss of information (Fig. 2, fourth step) . The weights determine the contribution of each representative cNMF curve to a given signal-versus-time curve, and thus, allows one to separate pixels dominated by one of the NP patterns of CA uptake/washout behavior from pixels that are characterized by a mixture of several cNMF patterns.
To generate cNMF curve pattern maps visualizing the contributions of the NP different patterns to each pixel in the ROI, the weights of each cNMF curve in a pixel were expressed as the fraction of sum of the weights in that pixel. Applying an encoder with NP binary cells that has two NP states, two different approaches were used to create pattern masks: 1) each pixel is assigned to the pattern with the maximum normalized weight (Decision Map 1), as done previously (24) , and 2) each pixel is assigned either to a single pattern or a mixture out of 2 to NP patterns (Decision Map 2)-that is, if the normalized weight difference of the pattern with the maximum weight to one or more of the other pattern weights is less than 25%, the pixel is assigned to a pattern mixture; otherwise, it is assigned to the dominant pattern.
Pixels with a maximum signal enhancement [S Enh (k), Eq. [3] ] of fewer than 4 standard deviations of the precontrast signal (mean 6 SD) were assigned as no contrast regions; thus, unlike before (24), low contrast regions were included in the analysis and spatial mapping.
RESULTS

Significance of Selection of NP
The significance of choosing the NP based on tumor characteristics is illustrated in Figure 1 . As shown for a representative tumor slice in Figure 1a , PCA produced two distinct PCs followed by higher-order PCs depicting noise. The corresponding cNMF maps of this tumor slice with associated cNMF curves for NP set to 2 and 3, respectively, are shown in Figure 1b . For 2 NP, two distinct cNMF patterns are identified; for three NP, however, the second and third pattern are very noisy with visually overlapping pattern curves due to data overfitting and the inability to reproducibly/accurately assign a pixel to pattern 2 or 3. In a second example (Fig. 1c) , PCA on two different slices in a heterogeneous flank tumor demonstrates that the number of PCs, with a signal level significantly different from the noise on the PC curve, may vary between slices in a single tumor. th PC. The red arrow denotes the occasional occurring PC above the defined threshold following one or more PCs below the defined threshold; these high-order PCs contribute generally little (<0.05%) to the total signal. (b) Accuracy per tumor for each selection criterion and each tumor is represented by the closed signs, with the open bars representing the corresponding mean 6 standard error (SE) averaged over the 21 tumors. Accuracy per tumor was calculated as the percentage of total slices for which the NP determined by each selection criterion matched the manually determined NP. SNR had the highest accuracy, which could be further improved for tumors with low CA uptake by lowering the threshold from 5 to 2. The accuracy for the selection criteria HAUC, SD Th , and S Enh deviated significantly from the desired 100%, contrary to SNR for both thresholds (P < 0.0001 for HAUC and SD Th , P ¼ 0.0033 for S Enh , P ¼ 0.0830 for SNR Th5 , and P ¼ 0.1864 for SNR Th2 ; one sample t test with a theoretical mean of 100%; two-tailed P values).
Thus, to avoid over-or underfitting to characterize the patterns present across a tumor, it is essential to adjust the NP to reflect the number of physiological relevant patterns describing the tumor microenvironments present in each tumor slice.
Automation of DCE-MRI Analysis
The following three out of four steps involved in the proposed DCE-MRI data analysis (Fig. 2) have been automated.
Automatic Determination of S 0
The automated selection of the precontrast signal, as detailed in the method section, accounts for variable injection time points due to manual injection of the CA and specifies the actual arrival time of the CA at the tumor-healthy tissue interface (Fig. 2 , second step; Supporting Fig. S1 discusses ROI versus pixel-based calculation of the S 0 ).
Automatic Selection of Significant NP
The automatic selection criteria of NP were compared with NP determined from visual inspection of PC curves (Fig. 1 ) by up to three readers (S.H., R.S., and E.A.). Representative examples of the four methods for automatic selection of NP are presented from tumor slices of HEK tumor #1 in Figure 3a . For the determination of NP, only consecutive PCs above a predefined threshold were selected because higher PCs above the defined threshold, but following one or more PCs below the threshold (Fig.  3a, red arrow) , contribute typically less than 0.05% to the overall signal. Because the SD Th method by definition assumes that the first PC (subtracted from the overall signal [Eq. [2] ]) is significant, the NP was calculated by adding one (depicted as þ 1* in Fig. 3a) to the NP determined from thresholding. Table 1 lists the accuracy for each tumor as the fraction of tumor slices where NP from the four selection criteria and visual inspections agreed. The selection criterion SNR was applied with thresholds 5 and 2, whereby the latter improved the accuracy for tumors with low contrast-to-noise ratio (CNR, boldface numbers in Table 1 ). The corresponding overall accuracy for each method was 50%, 53%, 76%, 87%, and 97% for HAUC, SD th , S Enh , SNR Th5 , and SNR Th2 , respectively (Table 1, Total). Figure 3b shows the accuracy per tumor averaged over 21 tumors for each of the pattern selection criteria. The most accurate criterion to select NP, SNR, is the only method (for both threshold levels) that does not significantly deviate from the desired 100% (P > 0.19).
cNMF and Pattern Assignments
A representative example of cNMF curves and corresponding weight maps are shown in Figure 4 (left, center). Based on pattern shape and weight, single patterns The number of slices per total tumor slices in agreement with the manual NP determination is shown for each tumor; boldface numbers show the improvement in NP determination by changing the SNR threshold in cases of overall low CNR for the raw data, often in tumors with extensive necrosis. Furthermore, the tumor volume covered by the DCE-MRI (V DCE ) and the time post tumor cell injection (PTI) that the DCE-MRI experiments were performed are listed. All cell lines were grown under sterile conditions in Dulbecco's modified essential medium, supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 mg/mL streptomycin at 37 C in 5% CO 2 . Cancer cells were injected subcutaneously in the right flank of Nod/SCID mice (The Jackson Laboratory, Bar Harbor, Maine, USA). a Tumors with very low CNR.
Automation of Pattern Recognition Analysis of DCE-MRI Data
or pattern mixtures were assigned automatically to each pixel and pattern masks created (Fig. 4, right) . Decision Map 1 (Fig. 4) shows the spatial distribution of the dominant pattern in each pixel, whereas the Decision Map 2 (Fig. 4) visualizes the spatial localization of single patterns and pattern mixtures, the latter inferring intratumoral heterogeneity at subpixel resolution. The in vivo DCE-MRI tumor data analyzed here do not have aligned ex vivo data. Thus, we validated the automated and optimized PR analysis by reanalyzing DCE-MRI data from experiments with aligned ex vivo data (Supporting Fig.  S2 ). While improving spatial mapping across tumor slices by slicewise analysis, we detect the same CA uptake behavior related to the tumor microenvironment as before (Supporting Fig. S2 ).
DISCUSSION
As shown previously, an unsupervised PR approach, using PCA followed by cNMF, can visualize intratumoral microenvironmental heterogeneity based on tumor vascular features (24) . Here, we successfully decreased user intervention and processing time by automating several analysis steps: 1) identification of the period before CA arrival at tumor, resulting in an automated determination of the mean precontrast signal for signal-versus-time curve normalization; 2) determination of NP, previously obtained via visual inspection and required for cNMF analysis; and 3) pattern assignments to visualize their spatial distribution across the tumor. Of the four developed and tested NP selection criteria, SNR showed the most promise with over 87% (threshold 5) or 97% (threshold 2) accuracy when compared with visual assessment. One limitation of this study is that the thresholds for the SNR criterion were determined empirically using solely preclinical tumor models, though a wide range of tumor types. A second limitation is that the 25% threshold for the weight difference for assigning patterns to mixtures was also defined empirically.
The wider applicability of these settings to DCE-MRI data from other tumor sites (preclinical) and clinical tumors, including the impact of CNR, spatial resolution, temporal resolution, and total acquisition time on the successful deconvolution of underlying patterns (Supporting Fig. S3 ) and their interpretation and biological/ physiological relevance will be the purpose of future research. When used alone or in conjunction with other modalities assessing intratumor heterogeneity (18, 19, 22) , the visualization of intratumoral vascular heterogeneity with fully automated, combined PCA/cNMF analysis may provide in preclinical models (24, 39) , and after successful clinical translation (40) , prognostic information as well as useful information for monitoring, therapy planning, and follow-up in longitudinal studies without the need for extensive tracer-kinetic modeling. In addition, this method can potentially improve and reduce the computation time of tracer-kinetic modeling by using average signal-versus-time curves of assigned pattern areas.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article. Figure 2 (second step). To reduce the impact of signal disturbances at the beginning of the DCE-MRI acquisition and signal variations as a result of a significant number of pixels with a faster contrast agent arrival than the majority of pixels, potentially visible in a signal difference above noise just prior NR CA (Fig. 1) , the first five and last five frames from NR 1 to NR CA are not included in the calculation of the average precontrast signal, resulting in a mean precontrast signal (6SD) of 780.5 Á 10 4 (64.1 Á 10 4 ) for the tumor shown here. F-misonidazole, which was administered prior to tumor excision for in vivo hypoxia imaging using positron emission tomography (data not shown). The fourth panel shows the corresponding H&E stain, visualizing viable and necrotic tissue. The holes in the tissue correspond to the fiduciary markers used to align the ex vivo data with the in vivo data. The automation successfully detected and mapped the three distinct CA uptake behaviors seen previously (12, 24) , in this case by slicebased analysis. As before, a delayed wash-in/wash-out behavior of the CA [green curve in (B)] was associated with tumor hypoxia (C). Pixels with low to no CA uptake with no CA washout [blue curve in (B)] tend to be associated with tumor necrosis. Of note is that the merged map demonstrates the appearance of pixels with mixtures of more than one pattern, indicating that a representative 8-mm-thick ex vivo slice may not capture fully the intrapixel heterogeneity in a corresponding 0.79-mm-thick in vivo slice. The agreement between manual NP determination and NP determination by HAUC and SD Th , respectively, was affected by shortening the total acquisition time. However, the NP determined manually and by S Enh and SNR Th5 were unaffected by using only the first 5 or 10 min of acquisition time, while agreement between manually and by SNR Th2 determined NP increased using only the signal-versus-time-curves for the first 5 or 10 min acquisition time. (C) Compared with a 20-min acquisition, visualization of intratumoral vascular heterogeneity by PR DCE-MRI analysis using the first 5 or 10 min acquisition time demonstrates that, at a respective temporal resolution of 5.487 and 6.585 s, patterns can be deconvolved as well using the shorter acquisitions than using the longer acquisitions employed to develop the methods. As in Figure 4 , the red, green, and blue cNMF curves (left) from a representative tumor slice (same as in Fig. 4 ) and their corresponding weight maps (right) show the spatial distribution and CA uptake behavior of three distinct patterns, indicative of wellvascularized (Pattern 1), hypoxic (Pattern 2), and necrotic (Pattern 3) tumor areas, respectively, as previously established (12, 24) . Decision Maps 1 and 2 were determined as explained in the Methods. In Decision Map 1, brown, orange, and cyan reflect Pattern 1 (indicative of well-vascularized tumor), Pattern 2 (indicative of hypoxia), and Pattern 3 (indicative of necrosis), respectively, while in Decision Map 2, Pattern 3 is displayed as dark blue, Pattern 1 as yellow, Pattern 2 as cyan, and corresponding mixtures as mixture colors. Shorter acquisition times may affect the overall identifiable shape of the signal-versus-time curves and thus may affect their criteria for interpretation (e.g., if the acquisition time is so short as to measure no CA washout in well-vascularized areas). Further, tracer-kinetic modeling or semiquantitative parameters may be affected as well by shortening of acquisition times, depending on the model used. Association of patterns with clinically relevant tumor characteristics may also differ from their preclinical interpretation and requiring future research beyond the scope of this study.
